Peter Morten

Peter Morten is the Global Health Economics and Payer Evidence Lead at AstraZeneca, where they focus on oncology and support the delivery of health economic and payer evidence activities. Previously, Peter worked as a Consultant in the HTA and Health Economics Division at Costello Medical, where they led UK HTA submissions to NICE and the SMC until August 2020. Peter holds a Master of Science in Economic Evaluation for Health Technology Assessment from the University of York and a Master's degree in Biochemistry and Molecular Biology from the University of Oxford.